Private equity secondaries are absorbing institutional capital at a pace not seen since the global financial crisis, with allocators redirecting $15 billion in commitments during the first quarter alone as traditional exit routes remain closed. Apollo Global Management reported secondary transaction volume up 47% year-over-year in its most recent quarterly disclosure, while J.P. Morgan's private markets desk noted LP-led deals now represent 62% of all secondary activity, reversing the GP-led dominance that characterized 2021 and 2022.
The shift reflects a structural problem in private markets: funds raised between 2015 and 2018 are now past their ten-year mark with portfolio companies still unexited. The IPO window that was supposed to provide liquidity has produced 23 venture-backed listings in 2024 versus 397 in 2021, according to Renaissance Capital. That forces Limited Partners—pension funds, endowments, sovereign wealth vehicles—to either extend fund lives or sell their positions at a discount to secondary buyers who can wait another cycle. The discount has narrowed from 18-22% in early 2023 to 8-12% now, per Apollo's data, making the trade more palatable for sellers and tighter for buyers.
What makes this cycle distinct is the buyer profile. Institutional allocators are no longer treating secondaries as opportunistic add-ons but as core private markets exposure. Benefits and Pensions Monitor notes Canadian pension plans have increased secondaries allocations from 3% of private equity portfolios in 2020 to 11% today. The logic: buying into funds with 4-6 years of remaining life offers faster J-curve resolution than committing to new funds with 12-15 year horizons. Apollo's secondaries platform has seen average holding periods compress to 4.2 years from 6.8 years a decade ago, a function of buying later-stage positions.
The risk is valuation lag. Private equity marks are notoriously slow to reflect public market corrections, and secondaries buyers are effectively purchasing portfolios at yesterday's prices. If rate cuts materialize in late 2025 or early 2026 and growth multiples re-expand, secondary buyers capture the upside. If private marks reset downward—especially in venture and growth equity—buyers inherit the repricing. The 8-12% discount only cushions so much.
Allocators should watch GP-led continuation fund volume in Q2 and Q3. If it ticks back above 40% of total secondaries activity, it signals GPs are regaining pricing power and LP-led distress is easing. Monitor the spread between NAV and transaction price: if it widens past 15% again, it means sellers are capitulating and buyers have room. The next inflection point is October, when several large university endowments finalize their fiscal-year rebalancing and either flood or starve the secondaries market based on their liquidity needs.
The IPO market is not coming back in 2025. That makes secondaries the only functioning liquidity mechanism for a $13 trillion private markets complex that doubled in size since 2018 without doubling its exit capacity.